• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Hematology

Aspirin associated with significantly higher rate of symptomatic venous thromboembolism compared to enoxaparin in patients undergoing hip or knee arthroplasty – the CRISTAL randomized trial

byZoya GomesandYuchen Dai
September 2, 2022
in Hematology, Orthopedic Surgery, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this randomized controlled trial that included 9711 patients undergoing hip or knee arthroplasty, treatment with aspirin vs enoxaparin resulted in symptomatic VTE in 3.45% vs 1.82% of patients, respectively.

2. Death within 90 days occurred in 0.07% of patients in the aspirin group and 0.05% in the enoxaparin group.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Venous thromboembolism (VTE) occurs in approximately 2% of patients following hip and knee arthroplasty procedures. The use of aspirin for thromboprophylaxis has increased between 2010 and 2021 due to its low cost, perceived safety and ease of administration. However, limited evidence exists regarding the safety and efficacy of aspirin as a sole prophylactic agent, hence the objective of this study was to determine whether aspirin was noninferior to enoxaparin in preventing symptomatic VTE after total hip arthroplasty (THA) or total knee arthroplasty (TKA). A total of 9711 patients undergoing THA or TKA were enrolled in this trial between April 2019 and December 2020. Patients were randomized to receive either 100mg/d of aspirin (n=5675) or 40mg/d of enoxaparin (n=4036) for 35 days post-THA and for 14 days post-TKA. The primary outcome in this study was symptomatic VTE within 90 days, which included pulmonary embolism and deep venous thrombosis. Secondary outcomes included death and major bleeding within 90 days. Within 90 days of surgery, symptomatic VTE occurred in 256 patients, with 79 cases of PE, 18 cases of above-knee DVT and 174 cases of below-knee DVT. The rate of symptomatic VTE in the aspirin group was 3.45%, and in the enoxaparin group it was 1.82%. A limitation to this study was the loss to follow-up at a rate of 5.2%, which could have led to some outcomes being missed. A strength of this study was its large sample size.

Click to read the study in JAMA

Click to read an accompanying editorial in JAMA

Relevant Reading: Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: a systematic review and meta-analysis

RELATED REPORTS

#VisualAbstract: Thromboprophylaxis with aspirin is non-inferior to low-molecular-weight heparin in preventing death for patients with orthopedic trauma

Low-dose low-molecular weight heparin comparable to intermediate-dose for risk of venous thromboembolism in peripartum women

#VisualAbstract: Aspirin associated with significantly higher rate of symptomatic venous thromboembolism compared to enoxaparin in patients undergoing hip or knee arthroplasty

In-Depth [randomized controlled trial]: In this study, a total of 9711 patients were included (median age, 68 years; 56.8% female). Within 90 days of THA or TKA, symptomatic VTE occurred at a rate of 3.45% (187 of 5416 patients) in the aspirin group, and 1.82% (69 of 3787 patients) in the enoxaparin group (estimated difference, 1.97%; 95% CI, 0.54%-3.41%). This trial demonstrated significant superiority for enoxaparin (P=.007), and failed to meet the criterion for noninferiority for aspirin. Death within 90 days occurred in 4 of 5675 patients (0.07%) in the aspirin group and 2 of 4036 patients (0.05%) in the enoxaparin group (estimated difference, 0.05%; 95% CI, -0.05% to 0.15%). Major bleeding events occurred in 17 of 5401 patients (0.31%) in the aspirin group, and 15 of 3779 patients (0.40%) in the enoxaparin group (estimated difference, -0.05%; 95% CI, -0.25% to 0.04%). The median time to diagnosis of symptomatic VTE was 7.5 days (IQR, 5-19 days) in the aspirin group and 12 days (IQR, 7-25 days) in the enoxaparin group.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: deep vein thrombosis (DVT)pulmonary embolismtotal hip replacementtotal knee replacementvenous thromboembolism (VTE)
Previous Post

COVID-19 adenoviral but not mRNA vaccines are associated with adverse cardiovascular events

Next Post

Nirmatrelvir associated with improved COVID-19 outcomes in older adults

RelatedReports

#VisualAbstract: Thromboprophylaxis with aspirin is non-inferior to low-molecular-weight heparin in preventing death for patients with orthopedic trauma
StudyGraphics

#VisualAbstract: Thromboprophylaxis with aspirin is non-inferior to low-molecular-weight heparin in preventing death for patients with orthopedic trauma

January 24, 2023
Women electing abortion more likely to be victims of domestic violence
Chronic Disease

Low-dose low-molecular weight heparin comparable to intermediate-dose for risk of venous thromboembolism in peripartum women

November 29, 2022
#VisualAbstract: Nirmatrelvir associated with improved COVID-19 outcomes in older adults
StudyGraphics

#VisualAbstract: Aspirin associated with significantly higher rate of symptomatic venous thromboembolism compared to enoxaparin in patients undergoing hip or knee arthroplasty

September 8, 2022
AAP supports mandatory influenza vaccination of health care providers
Infectious Disease

COVID-19 adenoviral but not mRNA vaccines are associated with adverse cardiovascular events

September 5, 2022
Next Post
Poor olfaction linked to increased mortality in older adults

Nirmatrelvir associated with improved COVID-19 outcomes in older adults

Prenatal antidepressant exposure may increase risk of poor motor development

Risk of gestational diabetes diagnosis significantly increased among individuals with high polygenic risk scores and low levels of physical activity

Patient Basics: Thrombotic Stroke

Screening patients with atrial fibrillation with an implantable loop recorder does not decrease the incidence of subsequent stroke

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher body mass index may be associated with altered vitamin D levels and metabolism
  • #VisualAbstract: Torsemide does not provide additional decrease in mortality compared to furosemide among patients hospitalized for heart failure
  • Community-based adult vision screening program increases access to eye care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options